Use this list to determine which medications require special safeguards to reduce the risk of errors and minimize harm.
Resource Library
Whether you have experienced a medication error in your organization or you are proactively implementing prevention strategies, you are not alone. Thousands of organizations worldwide have relied on ISMP's resources for institutional change to reduce errors on a daily basis. These resources are developed from ISMP's review of reports through its national error reporting programs, peer-reviewed articles in its publications, and/or consensus gathering summits on topics pertinent to specific errors or hazards. ISMP offers a wide range of downloadable and easy to use resources. Many are free.
All Resources
Easy-to-use Wall Charts cover topics of importance to pharmacists, nurses, and specialty practitioners.
This list includes look-alike and sound-alike name pairs. Use this list to determine which medications require special safeguards to reduce the risk of errors and minimize harm.
Beyond Blame is a must-see for all who are responsible for patient care. The award-winning DVD introduces viewers to “Just Culture,” a way of thinking that fixes problems rather than assigning fault.
Problem: Inadvertent tubing misconnections pose a significant risk to patients. They often occur when luer-compatible tubing is mistakenly connected to another type of tubing into which it can fit but for which it was not designed. To help prevent dangerous misconnections, the International...
In the latest issue of ISMP’s Quarter Watch , we examine a full year of adverse drug event reports received by the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) during 2017, to identify the most frequently named suspect drugs in four distinctive and severe adverse drug...
Between June and July 2018, ISMP conducted a survey on high-alert medications in acute care settings to learn about possible additions or deletions before updating our longstanding list. High-alert medications are an essential component of drug therapy, but they carry a significant risk of causing...
Methotrexate is a folic acid antagonist that was originally approved to treat a variety of cancers. Used for oncologic indications, methotrexate is administered in cyclical frequencies and in variable doses based on body surface area and the type of cancer being treated—for example, 12 g/m 2 per...
The Case for Medication Safety Officers (MSO) , an ISMP white paper, draws on ISMP’s years of experience in medication safety to provide detailed information for hospital leadership on the value a MSO can provide. Since the July 2006 National Academy of Medicine (formerly the Institute of Medicine)...